Qiagen NV Bullish perspective Coronavirus Stock $qgen
QGEN announced the shipping of its latest QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation purposes. The latest test kit helps detect the novel coronavirus SARS-CoV-2, thus adding rapid Sample to Insight syndromic testing to the company’s molecular testing solutions portfolio during the public health emergency.
Currently, QIAGEN is on track to ship QIAstat-Dx testing kits to public health institutions in other regions, including Europe, South-East Asia and the Middle East. Notably, the QIAstat-Dx system was introduced in Europe in 2018, after receiving the CE mark. The system was also cleared by the FDA in mid-2019.
Daily chart to follow.
Company profile
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
Currently, QIAGEN is on track to ship QIAstat-Dx testing kits to public health institutions in other regions, including Europe, South-East Asia and the Middle East. Notably, the QIAstat-Dx system was introduced in Europe in 2018, after receiving the CE mark. The system was also cleared by the FDA in mid-2019.
Daily chart to follow.
Company profile
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
تعليق:
